Amount
$169,523,999
Recipient
Novo Nordisk Pharmaceuticals Pty Ltd
Company — NSW
Selection Process
Direct Award
Period
31 Dec 2022 — 29 Jun 2027
Approved: 09 Feb 2023

Purpose

Procurement method: Limited tender

Program

National Blood Authority

National Blood Authority

Data Source

Source: AusTender
Category: UNSPSC 85100000
State: NSW | Postcode: 2060